|
|
Volumn 37, Issue 4, 2005, Pages 1804-1805
|
|
Improved graft survival in ABO-incompatible living donor kidney transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
15 DEOXYSPERGUALIN;
ANTIBODY;
AZATHIOPRINE;
CYCLOSPORIN A;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NAFAMSTAT;
PREDNISONE;
STEROID;
TACROLIMUS;
ANTIBODY TITER;
ANTICOAGULANT THERAPY;
BLOOD GROUP ABO INCOMPATIBILITY;
BLOOD GROUP ABO SYSTEM;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISEASE SEVERITY;
GRAFT FAILURE;
GRAFT SURVIVAL;
HEALTH CENTER;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION COMPLICATION;
KIDNEY GRAFT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
PLASMAPHERESIS;
POSTOPERATIVE PERIOD;
PREOPERATIVE PERIOD;
PRIORITY JOURNAL;
SPLENECTOMY;
STEROID THERAPY;
SURGICAL PATIENT;
SURVIVAL RATE;
SURVIVAL TIME;
ABO BLOOD-GROUP SYSTEM;
BLOOD GROUP INCOMPATIBILITY;
DRUG THERAPY, COMBINATION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVING DONORS;
PLASMAPHERESIS;
PREOPERATIVE CARE;
RETROSPECTIVE STUDIES;
SPLENECTOMY;
|
|
EID: 20344372196
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.02.107 Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (10)
|
